FDA Orange Book · active-ingredient family
Cefazolin sodium
Cefazolin sodium is approved as 6 brand and 35 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.
Reference-listed drug:CEFAZOLIN SODIUM · NDA 211413
6
Brand (NDA)
35
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · injectable, powder, solution
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| CEFAZOLIN SODIUMRLD×2 | HQ SPCLT PHARMA | NDA 211413 | — | May 08, 2023 | |
| CEFAZOLIN SODIUMRLD×2 | HIKMA | NDA 216109 | — | Oct 07, 2022 | |
| CEFAZOLIN IN DEXTROSERLD×3 | BAXTER HLTHCARE CORP | NDA 207131 | — | Feb 01, 2021 | |
| CEFAZOLIN AND DEXTROSERLD×4 | B BRAUN | NDA 050779 | — | Jul 27, 2000 | |
| ANCEF IN DEXTROSE 5% IN PLASTIC CONTAINERRLD×4 | BAXTER HLTHCARE | NDA 050566 | — | Jun 08, 1983 | |
| ANCEFRLD×5 | GLAXOSMITHKLINE | NDA 050461 | — | Approved Prior to Jan 1, 1982 |
Generic (ANDA) products (35)
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| CEFAZOLIN SODIUM | QILU ANTIBIOTICS | ANDA 209217 | AP | Oct 17, 2018 | |
| CEFAZOLIN SODIUM | HOSPIRA | ANDA 201654 | — | Feb 03, 2016 | |
| CEFAZOLIN SODIUM×3 | QILU ANTIBIOTICS | ANDA 203661 | AP | Dec 28, 2015 | |
| CEFAZOLIN SODIUM×2 | CEPHAZONE PHARMA | ANDA 065280 | — | Mar 18, 2009 | |
| CEFAZOLIN SODIUM | CEPHAZONE PHARMA | ANDA 065295 | — | Mar 18, 2009 | |
| CEFAZOLIN SODIUM | CEPHAZONE PHARMA | ANDA 065296 | — | Mar 18, 2009 | |
| CEFAZOLIN SODIUM×2 | ACS DOBFAR | ANDA 065303 | AP | Oct 22, 2008 | |
| CEFAZOLIN SODIUM×2 | ACS DOBFAR | ANDA 065306 | AP | Oct 22, 2008 | |
| CEFAZOLIN SODIUM×2 | AUROBINDO PHARMA | ANDA 065395 | — | Aug 08, 2008 | |
| CEFAZOLIN SODIUM | SANDOZ | ANDA 065345 | — | May 09, 2007 | |
| CEFAZOLIN SODIUM×2 | SAMSON MEDCL | ANDA 065141 | — | Nov 29, 2006 | |
| CEFAZOLIN SODIUM | HOSPIRA INC | ANDA 065244 | — | Aug 12, 2005 | |
| CEFAZOLIN SODIUM | HOSPIRA INC | ANDA 065247 | — | Aug 12, 2005 | |
| CEFAZOLIN SODIUM×2 | HOSPIRA INC | ANDA 065226 | — | Apr 21, 2005 | |
| CEFAZOLIN SODIUM | HIKMA FARMACEUTICA | ANDA 065143 | AP | Oct 18, 2004 | |
| CEFAZOLIN SODIUM×2 | HIKMA FARMACEUTICA | ANDA 065047 | AP | Sep 18, 2001 | |
| CEFAZOLIN SODIUM×2 | FRESENIUS KABI USA | ANDA 064169 | — | Aug 14, 1998 | |
| CEFAZOLIN SODIUM×2 | FRESENIUS KABI USA | ANDA 064170 | — | Mar 18, 1998 | |
| CEFAZOLIN SODIUM | GLAXOSMITHKLINE | ANDA 064033 | — | Oct 31, 1993 | |
| CEFAZOLIN SODIUM | FACTA FARMA | ANDA 063207 | — | Dec 27, 1991 | |
| CEFAZOLIN SODIUM×2 | FACTA FARMA | ANDA 063209 | — | Dec 27, 1991 | |
| CEFAZOLIN SODIUM | FACTA FARMA | ANDA 063214 | — | Dec 27, 1991 | |
| CEFAZOLIN SODIUM | STERI PHARMA | ANDA 063208 | — | Dec 27, 1991 | |
| CEFAZOLIN SODIUM | STERI PHARMA | ANDA 063216 | — | Dec 27, 1991 | |
| ANCEF IN PLASTIC CONTAINER×2 | BAXTER HLTHCARE | ANDA 063002 | — | Mar 28, 1991 | |
| CEFAZOLIN SODIUM×2 | TEVA PHARMS | ANDA 063018 | — | Mar 05, 1990 | |
| CEFAZOLIN SODIUM×3 | DR REDDYS | ANDA 062988 | — | Dec 29, 1989 | |
| CEFAZOLIN SODIUM×3 | DR REDDYS | ANDA 062989 | — | Dec 29, 1989 | |
| CEFAZOLIN SODIUM×3 | TEVA PHARMS | ANDA 063016 | — | Mar 14, 1989 | |
| CEFAZOLIN SODIUM×3 | SANDOZ | ANDA 062831 | AP | Dec 09, 1988 | |
| CEFAZOLIN SODIUM×5 | BEDFORD | ANDA 062894 | — | Jul 21, 1988 | |
| CEFAZOLIN SODIUM×6 | HIKMA | ANDA 062807 | — | Jan 12, 1988 | |
| CEFAZOLIN SODIUM×4 | ABRAXIS PHARM | ANDA 062688 | — | Nov 17, 1986 | |
| KEFZOL×2 | LILLY | ANDA 062557 | — | Sep 10, 1985 | |
| KEFZOL×5 | ACS DOBFAR | ANDA 061773 | — | Approved Prior to Jan 1, 1982 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Cefazolin sodium — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

